J
Jeff Boyd
Researcher at Florida International University
Publications - 70
Citations - 13881
Jeff Boyd is an academic researcher from Florida International University. The author has contributed to research in topics: Tumor suppressor gene & Gene. The author has an hindex of 42, co-authored 69 publications receiving 13229 citations. Previous affiliations of Jeff Boyd include Research Triangle Park & University of Pennsylvania.
Papers
More filters
Journal Article
What women and their physicians need to know about the UKCTOCS study and ovarian cancer screening
Calaneet Balas,David Barley,Elisabeth Baugh,Andrew Berchuck,Jeff Boyd,Codruta Chiuzan,Sarah DeFeo,Mark H. Ebell,Annie Ellis,Kathleen Gavin,Bruce Levin,Kristen A. Matteson,Audra Moran,Steven A. Narod,Chad Ramsey,Michael V. Seiden,Sherri L. Stewart +16 more
TL;DR: The consensus of the Banbury group is in accord with the published conclusions of the UKCTOCS trial: It is premature to recommend MMS for the early detection of ovarian cancer at this time.
Journal ArticleDOI
A case report of EGFR L861Q mutation in synchronous de novo small cell and non-small cell lung cancer: molecular interrogation identifies origin and potential options for targeted therapy
TL;DR: In this article , a unique case of synchronous malignancies with a possible common origin from a molecular perspective is presented, where mutations in epidermal growth factor receptor (EGFR) are targeted using tyrosine kinase inhibitors providing new treatment opportunities for lung cancer.
Fallopian T ube a nd P rimary P eritoneal C arcinomas A ssociated With BRCA Mutations
Douglas A. Levine,Peter A. Argenta,Cindy J. Yee,David S. Marshall,Narciso Olvera,Faina Bogomolniy,Jamal A. Rahaman,Mark E. Robson,Kenneth Offit,Richard R. Barakat,Robert A. Soslow,Jeff Boyd +11 more
TL;DR: Although the lifetime risks of FTC or PPC for patients with BRCA heterozygotes are greater than those for the general population, the absolute risks seem relatively low.
Journal ArticleDOI
Breast cancer and importance of zygosity determination in triplet sisters
TL;DR: The unaffected triplet, the proband, was found to be monozygotic with her deceased sister through DNA testing of tumor blocks and dizygotic to her living affected sister.